These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2552845)

  • 1. Plasma level, urinary excretion, and metabolic production of cGMP during gestation in rats.
    Conrad KP; Vernier KA
    Am J Physiol; 1989 Oct; 257(4 Pt 2):R847-53. PubMed ID: 2552845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of increased nitric oxide biosynthesis during pregnancy in rats.
    Conrad KP; Joffe GM; Kruszyna H; Kruszyna R; Rochelle LG; Smith RP; Chavez JE; Mosher MD
    FASEB J; 1993 Apr; 7(6):566-71. PubMed ID: 7682524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog.
    Blonde L; Wehmann RE; Steiner AL
    J Clin Invest; 1974 Jan; 53(1):163-72. PubMed ID: 4357610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide and cyclic guanosine-3'5'-monophosphate in hypertensive pregnancy and during nifedipine treatment.
    Manninen A; Vuorinen P; Laippala P; Tuimala R; Vapaatalo H
    Pharmacol Toxicol; 1994 Mar; 74(3):153-7. PubMed ID: 8008721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary cGMP as biological marker of the renal activity of atrial natriuretic factor.
    Wong KR; Xie MH; Shi LB; Liu FY; Huang CL; Gardner DG; Cogan MG
    Am J Physiol; 1988 Dec; 255(6 Pt 2):F1220-4. PubMed ID: 2849318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal factors modulate the increase in vasoactive substances during rat pregnancy.
    Giacaman A; Salas SP; Rosso P
    Hypertens Pregnancy; 1999; 18(1):23-34. PubMed ID: 10463997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide biosynthesis during pregnancy: implications for circulatory changes.
    McLaughlin MK; Conrad KP
    Clin Exp Pharmacol Physiol; 1995 Feb; 22(2):164-71. PubMed ID: 7621611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANF-mediated renal cGMP generation in congestive heart failure.
    Margulies KB; Heublein DM; Perrella MA; Burnett JC
    Am J Physiol; 1991 Apr; 260(4 Pt 2):F562-8. PubMed ID: 1849364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pressor responsiveness in pseudopregnant and pregnant rats: role of maternal factors.
    Paller MS; Gregorini G; Ferris TF
    Am J Physiol; 1989 Oct; 257(4 Pt 2):R866-71. PubMed ID: 2802003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses.
    Tolins JP; Palmer RM; Moncada S; Raij L
    Am J Physiol; 1990 Mar; 258(3 Pt 2):H655-62. PubMed ID: 2156453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced urinary excretion of cGMP in liver cirrhosis. Relationship to hemodynamic changes, neurohormonal activation, and urinary sodium excretion.
    Fernández-Rodriguez CM; Prieto J; Quiroga J; Zozaya JM; Andrade A; Rodriguez-Ortigosa C
    Dig Dis Sci; 1997 Jul; 42(7):1416-20. PubMed ID: 9246039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy alters nitric oxide synthase and natriuretic peptide systems in the rat left ventricle.
    Jankowski M; Wang D; Mukaddam-Daher S; Gutkowska J
    J Endocrinol; 2005 Jan; 184(1):209-17. PubMed ID: 15642797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osmoregulation in pseudopregnant and prolactin-treated rats: comparison with normal gestation.
    Barron WM; Lindheimer MD
    Am J Physiol; 1988 Mar; 254(3 Pt 2):R478-84. PubMed ID: 3348441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible mechanisms for changes in renal hemodynamics during pregnancy: studies from animal models.
    Conrad KP
    Am J Kidney Dis; 1987 Apr; 9(4):253-9. PubMed ID: 3554994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated plasma and urinary guanosine 3':5'-monophosphate and increased production rate in patients with neoplastic diseases.
    Chawla RK; Shlaer SM; Lawson DH; Murray TG; Schmidt F; Shoji M; Nixon DW; Richmond A; Rudman D
    Cancer Res; 1980 Nov; 40(11):3915-20. PubMed ID: 6258769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary NO3- excretion as an indicator of nitric oxide formation in vivo during oral administration of L-arginine or L-name in rats.
    Boger RH; Bode-Boger SM; Gerecke U; Gutzki FM; Tsikas D; Frolich JC
    Clin Exp Pharmacol Physiol; 1996 Jan; 23(1):11-5. PubMed ID: 8713490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurohumoral mechanism in the natriuretic action of intracerebroventricular administration of renin.
    Zavala L; Barbella Y; Israel A
    J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):39-44. PubMed ID: 15136973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cGMP phosphodiesterase activity mediates renal resistance to ANP in rats with bile duct ligation.
    Ni XP; Safai M; Gardner DG; Humphreys MH
    Kidney Int; 2001 Apr; 59(4):1264-73. PubMed ID: 11260387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for hormonal imbalance after methadone treatment in pregnant and pseudopregnant rats.
    Bui QQ; Tran MB; West WL
    Proc Soc Exp Biol Med; 1983 Jul; 173(3):398-407. PubMed ID: 6306676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.